Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.239

Overexpression of NDRG2 Can Inhibit Neuroblastoma Cell Proliferation through Negative Regulation by CYR61  

Zhang, Zhi-Guo (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital)
Li, Gang (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital)
Feng, Da-Yun (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital)
Zhang, Jian (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University)
Zhang, Jing (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University)
Qin, Huai-Zhou (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital)
Ma, Lian-Ting (Postdoctoral Research Station of Neurosurgery, Wuhan General Hospital of Guangzhou Command, PLA)
Gao, Guo-Dong (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital)
Wu, Lin (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 239-244 More about this Journal
Abstract
Several recent studies have showed that the n-myc downstream regulated gene 2 (NDRG2) is a new tumor suppressor gene, and that it plays an important role in tumor suppression in several cancers or cancer cell lines. However, few studies focused on its function in neuroblastoma cells. In the present investigation, we demonstrated that NDRG2 overexpression inhibited their proliferation. Using a cDNA microarray, we found that overexpression of NDRG2 inhibited the expression of cysteine-rich protein 61 (CYR61), a proliferation related gene. From our research, CYR61 may partially hinder NDRG2-mediated inhibition of cell proliferation. Overexpression of NDRG2 resulted in accumulation of cells in the G1 phase, which was accompanied by upregulation of p21 and p27 and downregulation of CDK4 and cyclin D1. Taken together, these data indicate that NDRG2 inhibits the proliferation of neuroblastoma cells partially through suppression of CYR61. Our findings offer novel insights into the physiological roles of NDRG2 in neuroblastoma cell proliferation, and NDRG2 may prove to be effective candidate for the treatment of children with neuroblastoma.
Keywords
NDRG2; CYR61; neuroblastoma; proliferation;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Xie D, Yin D, Wang HJ, et al (2004). Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res, 10, 2072-81.   DOI   ScienceOn
2 Zhao H, Zhang J, Lu J, et al (2008). Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer. BMC Cancer, 8, 303-11.   DOI   ScienceOn
3 Tong X, Xie D, O'Kelly J, et al (2001). Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem, 276, 47709-14.   DOI   ScienceOn
4 Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R (2002). Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene, 21, 8178-85.   DOI   ScienceOn
5 Tschan MP, Shan D, Laedrach J, et al (2010). NDRG1/2 expression is inhibited in primary acute myeloid leukemia. Leuk Res, 34, 393-8   DOI   ScienceOn
6 Xie D, Yin D, Tong X, et al (2004). Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res, 64, 1987-96.   DOI   ScienceOn
7 Yang J, Li Y, Wu L, et al (2010). NDRG2 in rat liver regeneration: role in proliferation and apoptosis. Wound Repair Regen, 18, 524-31.   DOI   ScienceOn
8 Yang J, Zheng J, Wu L, et al (2011). NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-beta1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS One, 6, e27710.   DOI
9 Yao L, Zhang J, Liu X (2008). NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin, 40, 625-35.   DOI   ScienceOn
10 Yu Y, Gao Y, Wang H, et al (2008). The matrix protein CCN1 (CYR61). promotes proliferation, migration and tube formation of endothelial progenitor cells. Exp Cell Res, 314, 3198-208.   DOI   ScienceOn
11 Ma J, Jin H, Wang H, et al (2008). Expression of NDRG2 in clear cell renal cell carcinoma. Biol Pharm Bull, 31, 1316-20.   DOI   ScienceOn
12 Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C (2011). Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2). in human cancers with focus on breast cancer. BMC Cancer, 11, 14-21.   DOI   ScienceOn
13 Lorentzen A, Vogel LK, Lewinsky RH, et al (2007). Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer, 7, 192-9.   DOI
14 Lusis EA, Watson MA, Chicoine MR, et al (2005). Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res, 65, 7121-6.   DOI   ScienceOn
15 Matthay KK (1995). Neuroblastoma: a clinical challenge and biologic puzzle. CA Cancer J Clin, 45, 179-92.   DOI   ScienceOn
16 Salic A, Mitchison TJ (2008). A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA, 105, 2415-20.   DOI   ScienceOn
17 Kim A, Kim MJ, Yang Y, et al (2009). Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis, 30, 927-36.   DOI   ScienceOn
18 Shi H, Jin H, Chu D, et al (2009). Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull, 32, 968-75.   DOI   ScienceOn
19 Shi H, Li N, Li S, et al (2010). Expression of NDRG2 in esophageal squamous cell carcinoma. Cancer Sci, 101, 1292-9.   DOI   ScienceOn
20 Tong X, O'Kelly J, Xie D, et al (2004). Cyr61 suppresses the growth of non-small-cell lung cancer cells via the betacatenin-c-myc-p53 pathway. Oncogene, 23, 4847-55.   DOI   ScienceOn
21 Foletta VC, Prior MJ, Stupka N, et al (2009). NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol, 587, 1619-34.   DOI   ScienceOn
22 Jandova J, Beyer TE, Meuillet EJ, Watts GS (2012). The matrix protein CCN1/CYR61 is required for alpha(V). beta(5). -mediated cancer cell migration. Cell Biochem Funct, 30, 687-95   DOI   ScienceOn
23 Kang K, Jung H, Nam S, Lim JS (2011). NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells. Immune Netw, 11, 348-57.   DOI   ScienceOn
24 Kim JT, Kim JW, Kang YH, et al (2012). NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/beta-catenin signaling. FEBS Lett, 586, 3962-8.   DOI   ScienceOn
25 Kim YJ, Yoon SY, Kim JT, et al (2009). NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma. Carcinogenesis, 30, 598-605.   DOI   ScienceOn
26 Chien W, Kumagai T, Miller CW, et al (2004). Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem, 279, 53087-96.   DOI   ScienceOn
27 Lee DC, Kang YK, Kim WH, et al (2008). Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res, 68, 4210-20.   DOI   ScienceOn
28 Lee KB, Byun HJ, Park SH, et al (2012). CYR61 controls p53 and NF-kappaB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells. Cancer Lett, 315, 86-95.   DOI   ScienceOn
29 Li ZQ, Ding W, Sun SJ, et al (2012). Cyr61/CCN1 is regulated by Wnt/beta-catenin signaling and plays an important role in the progression of hepatocellular carcinoma. PLoS One, 7, e35754.   DOI
30 Choi SC, Yoon SR, Park YP, et al (2007). Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med, 39, 705-14.   DOI   ScienceOn
31 Deng Y, Yao L, Chau L, et al (2003). N-Myc downstreamregulated gene 2 (NDRG2). inhibits glioblastoma cell proliferation. Int J Cancer, 106, 342-7.   DOI   ScienceOn
32 Kim YJ, Yoon SY, Kim JT, et al (2009). NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int J Cancer, 124, 7-15.   DOI   ScienceOn
33 Xu C, Zheng J, Zhang H, et al (2012). MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo. Asian Pac J Cancer Prev, 13, 3233-8   과학기술학회마을   DOI   ScienceOn
34 Sabile AA, Arlt MJ, Muff R, et al (2012). Cyr61 expression in Osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. J Bone Miner Res, 27, 58-67   DOI   ScienceOn